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Axon extension at the growing tip requires elevated
local protein supply, with a capability sustainable
over long axons in varying environments. The exact
mechanisms, however, remain elusive. Here we re-
port that axon-promoting factors elicited a retro-
grade transport-dependent removal of proteasomes
from nascent axon terminals, thereby increasing pro-
tein stability at axon tips. Such an effect occurred
through phosphorylation of a dynein-interacting pro-
teasome adaptor protein Ecm29. During the transi-
tion from immature neurites to nascent axons in
cultured hippocampal neurons, live-cell imaging re-
vealed a significant increase of the retrograde axonal
transport of fluorescently labeled 20S proteasomes.
This retrograde proteasome transport depended on
neuron stage and increased with axon lengths.
Blockade of retrograde transport caused accumula-
tion of proteasomes, reduction of axon growth, and
attenuation of growth-associated Par6 at the axon
tip of newly polarized neurons. Our results delineate
a regulatory mechanism that controls proteasome
abundance via preferential transport required for
axon development in newborn neurons.
INTRODUCTION
Axon development starts with a process of symmetry breaking at
newborn neurons, where asymmetric accumulation and activa-
tion of proteins lead to axon and dendrite specification and
neuronal polarization (Cheng and Poo, 2012). Newly specified
axons then grow over long distances to reach their synaptic tar-
gets. For the initial specification and subsequent growth of
axons, it is essential to accumulate specific signaling or struc-
tural proteins at the growing axon tip and deplete these proteins
elsewhere. Such processes can be achieved by implementing a
local positive regulation at the axon tip over other neurites
through, for instance, preferential transport or degradation of
specific proteins (Cheng et al., 2011a; Namba et al., 2011). While
major studies have been focused on preferential transport of418 Developmental Cell 35, 418–431, November 23, 2015 ª2015 Elsproteins such as KIF5/kinesin-1, Par3, TrkB, and NgCAM (Ari-
mura et al., 2009; Burack et al., 2000; Kamal et al., 2000; Nakata
and Hirokawa, 2003; Nishimura et al., 2004), less understood are
the roles of preferential degradation of proteins in axon initiation
and growth.
In eukaryotes, protein degradation is governed by ubiquitin
proteasome system (UPS). Proteasome is an enzymatic mega
complex composed of at least 33 different subunits, assembled
into two parts—a highly conserved, catalytic 20S core particle
and one or two 19S regulatory particles. These particles
assemble independently with the help of cytoplasmic chaper-
ones before forming the 26S proteasome complex (Coux et al.,
1996; Murata et al., 2009). Recent studies indicate that UPS con-
tributes to axon growth and guidance (Campbell and Holt, 2001).
In cultured hippocampal neurons, for example, reducing protea-
some activity by pharmacological inhibitor MG132 or lactacystin
led to the formation of multiple axons (MAs), but the underlying
mechanism is unclear (Cheng et al., 2011a; Yan et al., 2006).
Likewise, cytoplasmic transport systems in neuritesmay dynam-
ically regulate proteasome translocations (Bingol et al., 2010;
Djakovic et al., 2012; Hamilton et al., 2012; Hamilton and Zito,
2013), but whether directional proteasome transport could be
regulated by extracellular signals, e.g., axon promoting factors,
in a manner that contributes to axon growth or asymmetric pro-
tein degradation in polarizing neurons remains unknown.
Here, we examined the spatiotemporal dynamics of protea-
somes in unpolarized and polarized neurons.We found an asym-
metric transport of 26S proteasomes that occurred early in
neuronal polarization and led to selective reduction of protein
degradation at the tip of the nascent axon. This process resulted
from an enhanced retrograde transport of proteasomes away
from the neuritic tip, via microtubule-based, dynein-mediated
transport. The axon-promoting factors cAMP and brain-derived
neurotrophic factor (BDNF) increased this retrograde protea-
some transport at nascent axon without affecting the antero-
grade direction. Biochemical assays showed an axon-pro-
moting signal promoted PKA-dependent phosphorylation on
the 26S proteasome adaptor extracellular mutant-29 (Ecm29)
that enhanced proteasome-dynein interaction. This Ecm29
phosphorylation could be triggered by BDNF in undifferentiated
neurites and contributed significantly to axon formation in vitro
and neuronal migration in vivo. Further, the degree of preferential
transport was stage dependent and became more profound at
later stages when cells exhibited extensively long axons. Suchevier Inc.
Figure 1. Reduced Proteasome Abundance Correlates with Axon Formation
(A and B) Neurites with high GFPu reporter accumulation (low degradation rate) showed high probability of becoming axons. (A) Images of two example neurons
on 1 and 3DIV, showing accumulation of GFPu in an undifferentiated neurite (marked by asterisk) that later became the axon. The intensity of GFPu is proportional
to the brightness of the grayscale image, with high-intensity rangemarked by the red color. Bar represents 25 mm. (B) Bar graphs summarizing results from all live-
imaging experiments as in (A), showing neurites that exhibiting the highest level of GFPu accumulation mostly became the axon. (Top) Neurites were ranked
according to the average fluorescence intensity (up to seven neurites) for all cells on 1 DIV (n = 90, from five independent experiments; **p < 0.001, ANOVA with
Tukey post hoc test). All GFPu values were normalized by co-transfected volume control tdTomato. (Middle) The average length of neurites, corresponding to
those shown in the panel above. (Bottom) The percentage of neurites that differentiated into axons on 3 DIV for the corresponding neurite groups shown in the
above panels.
(C) Inverse correlation between proteasome abundance and neurite length. Representative image of a 1 DIV neuron labeled with proteasome marker MV151
(100 mM, 1 hr). Histograms depict the distribution of average length (±SEM, n = 45; white bars) of seven longest neurites (ranked by length for each cell) and
average MV151 intensity (±SEM, n = 15; normalized to volume control GFP; red bars) of the neurites corresponding to the neurite groups shown on the right.
(D) Images of 3 DIV neurons with MV151 or MV152 labeling (100 mM, 1 hr) for proteasome abundance, immunostained for axon-specific Tau-1 (green), and
neuron-specific Tuj-1 (red). The MV151/MV152 fluorescent intensity is proportional to the brightness of the grayscale image.
(E) Measured MV151 and MV152 intensity along the axon and dendrites (average of five neurites) of the neuron shown in (D).
(legend continued on next page)
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phenomena can be explained by a simple mathematical model.
Together, these studies delineated a regulatory mechanism
for proteasome removal via phosphorylation of the adaptor
Ecm29, leading to differential protein stability required for axon
development.
RESULTS
Reduced Proteasome Abundance in Nascent Axons
In Vitro and In Vivo
To investigate the role of protein degradation in developing neu-
rons, we assessed the status of protein degradation in cultured
hippocampal neurons transfected with the short half-life protein
degradation reporter GFPu (Bence et al., 2001, 2005; Gilon et al.,
1998). Cells were examined 4 hr after plating. In unpolarized neu-
rons (i.e., neurons with multiple neurites of similar lengths) from
1 day in vitro (1 DIV) culture, we found that neurites with the high-
est GFPu intensity had a higher probability (0.73) of becoming
the axon (at 3 DIV) than those with lower GFPu intensity (proba-
bility < 0.1; Figures 1A and S1B). The observed GFPu intensity
difference was due to protein degradation, as confirmed by
transfecting cells with the long half-life (>24 hr) reporter
Enhanced Green Fluorescent Protein (EGFP), which exhibited
random patterns in unpolarized neurites, without any apparent
spatial correlation to their axonal fate (probability <0.3 each;
see Figures S1C and S1D).
The asymmetric distribution of GFPu may result from differ-
ential proteasome abundance or activity in the neurites. To
ascertain whether the asymmetry is due to uneven proteasome
abundance, we used fluorophor-coupled activity-based probe
BODIPY TMR-Ahx3L3VS (MV151) (Verdoes et al., 2006b).
MV151 covalently binds to the catalytic subunit b1, b2, and b5
of proteasomes with a binding capacity of one 20S core
harboring at most six MV151 molecules and has been used
for live-cell imaging and in-gel fluorescent labeling of functional
proteasome complexes (Verdoes et al., 2006a, 2006b) (also
see Figures S2A and S2B, which shows that approximately
90% of MV151-labeled puncta were co-transported with
ectopic expressed 20S proteasome subunit a4). By incubating
cultured hippocampal neurons withMV151 for 1 hr, we observed
an asymmetric distribution of MV151 fluorescence intensity
(normalized by volume control tdTomato) that inversely corre-
lated with the neurite length in unpolarized, multineurite neurons
at 1–2 DIV (Figure 1C). At 3 DIV, we found that neuritic processes
with the lowest MV151 fluorescence intensity (equivalent to pro-
teasome abundance) were likely to show highest immunostain-
ing of the axon marker Tau1 (in 42/50 cells; Figures 1D–1F).
Such a differential pattern of MV151 was specific to protea-
somes, as confirmed by the staining of a control compound
BODIPY TMR-Ahx3L3ES (MV152), which does not bind protea-
somes and showed a diffusive rather than differential pattern in
dendrites and axons (Figures 1D–1F). To further confirm that dif-(F) Summary of average MV151 and MV152 intensity (±SEM, n = 50, normalized
independent MV151/MV152 staining experiments similar to that shown in (D).
(G) Representative images of MV151 labeled, GFP transfected pyramidal neuron
displayed as rainbow RGB to emphasize differences in MV151 intensity, ranging fr
accumulation of MV151 signal in apical dendrite (arrow heads) and the reduction
volume control GFP.
420 Developmental Cell 35, 418–431, November 23, 2015 ª2015 Elsferential proteasome abundance between axons and dendrites
does appear in the developing brain, MV151 was injected into
the lateral ventricle at embryonic day 17 (E17). Examining
MV151-labeled cortical neurons at embryonic day 20 (E20) re-
vealed that trailing axons exhibited significantly lower MV151 in-
tensity (normalized to volume control GFP) as compared with
apical dendrites (Figure 1G). Thus, asymmetric proteasome
abundance appears in and correlates with axon development
both in vitro and in vivo.
Enhanced Retrograde Proteasome Transport
Correlates with Axon Growth and Increases with Axon
Lengths
To explore themechanism bywhich proteasomes are reduced in
nascent axons, we monitored the dynamics of MV151-labeled
proteasomes at three stages in axon development. We defined
stage 1 as neurons with undifferentiated multiple neurites (1
DIV), stage 2 as neurons with a single elongated neurite of a
length 1.5- to 2.0-fold of the average length of remaining neurites
(1–2 DIV), and stage 3 as neurons with a single extensively long
axon and multiple short neurites (3 DIV). Among these stages,
we found an early and persistent increase in the retrograde
movement of axonal proteasomes at tips of nascent axons
(Figures 2A and 2B). In the kymographs of MV151-labeled pro-
teasomes at stage 1, we found nearly 35% of proteasomes ex-
hibiting apparent anterograde (21%) and/or retrograde (12%)
motions in neurites, while the rest (67%) remained stationary
(Figure S2C). At stage 2, the majority of proteasomes in all neu-
rites became dynamic, and more retrograde than anterograde
motions were observed in the longest neurite (the nascent
axon). At stage 3, the increase of retrogrademovements became
more pronounced (10 events per 180 s; Figures 2B and S2C),
as shown by measuring the frequencies of anterograde and
retrograde movements that crossed the first 100 mm region of
axon (from the soma). Thus, the degree of retrograde flow and
hence the differential accumulation of proteasomes between
axon and short neurite tips correlate with the stages and in-
creases with the axon length.
In comparison, short neurites showed unchanged frequency
and average speed of proteasome movements in either antero-
grade or retrograde direction throughout stages 1 to 3 (Figures
2B, 2C, and S2C). In addition, the anterograde behaviors of pro-
teasome between axons and short neurites were comparable
throughout the three stages (Figures 2B and S2C), suggesting
that the differential proteasome abundance between axons
and short neurites was mainly due to an enhanced retrograde
removal, rather than a lack of anterograde supply of protea-
somes in axonal terminals.
To confirm this hypothesis, we disrupted the function and/or
distribution of retrograde motor dynein complexes in 1–2 DIV
neurons, prior to their axon determination. By both pharmaco-
logical and genetic approaches, we found that dynein activitiesby Tuj-1 staining; **p < 0.001, t test) of axons and dendrites from at least three
s in the rat cortical intermediate zone. Fluorescence intensity of MV151 is also
om low intensities (blue), over medium (green) to high intensities (red). Note the
in trailing axon (arrows). All MV151 values were normalized by co-transfected
evier Inc.
Figure 2. Selective Modulation of Retrograde and Anterograde Proteasome Transports in Developing Hippocampal Neurons
(A–C) Preferential increase in the number of retrogradely moving proteasomes in nascent axons. (A) Schematic diagram on developing neurons and kymographs
of proteasome trajectories (x axis distance, y axis time) generated from 180-s time-lapse images (90 frames; 0.5 frames/s), showing bidirectional movement of
proteasomes along neurites (marked by numbers), and the tracings of individual anterogradely (red) and retrogradely (black) moving as well as stationary (not
shown) proteasomes. Summary of frequencies (B) and velocity (C) of MV151-labeled proteasomes at three different stages from all experiments similar to that
shown above. Data represent mean ± SEM (n = 20–35 cells; ****p < 0.00001; n.s., not significant; comparedwith stage 1 neurons, ANOVAwith Dunnett’s post hoc
test).
(D–F) Proteasome accumulation at the axonal tip after dynein inhibition. (D) Images of 2 DIV neurons immunostained with antibodies specific for proteasome
subunit Rpt1, showing local Rpt1 accumulation at neurite tips after bath application of EHNA (0.5 mM; top) or Ciliobrevin D (Cilio D, 0.5mM; top) for 2 hr, or ectopic
expression of p50/dynamitin (‘‘p50-GFP’’; bottom) or dominant-negative C-terminal deleted Lis1 (‘‘GFP-DC-Lis1’’; bottom) for 24 hr. Insets are boxed regions of
axon growth cone at a higher magnification. ax, Tau-1 positive axon. den, dendrite. Arrows, proteasome accumulation at neurite tips. Bar represents 25 mm. (E)
Graph depicts summary of the immunostaining intensities of endogenous proteasome subunits Rpt-1 and PA28a in the most distal 18 mm region (including
growth cone) of the axons obtained from the above experiments (average of 20–25 cells; each data points were normalized to the average intensity of the first
5 mm). (F) Summary of quantitative measurements of Rpt1 intensity (±SEM, n = 20–25, compared with control set; **p < 0.001, Dunnett’s test) in neurite tips at two
different stages from all experiments similar to that shown above.
(G–I) Representative images and kymographs from ectopic p50-GFP or GFP-DC-LIS1 expressing neurons at 3 DIV (G), showing reduced retrograde proteasome
transport and unaffected anterograde transport (H). Dashed line marks the longest neurite subjected to kymograph analysis. Histograms in (H) represent average
number of directional events (±SEM, 20–35 cells each; ***p < 0.0001, compared to GFP control, Dunnett’s test) of mobile MV151-labeled proteasomes. (I)
Summary of average axon length (±SEM, n = 90; *p < 0.01, **p < 0.001, compared with control, Dunnett’s test) of control and EHNA/Cilio D-treated neurons, as
well as the relative neurite length (±SEM, from three independent experiments, n = 30 cells each; ***p < 0.0001, compared with control GFP, Dunnett’s test) of
neuron expressing p50-GFP, DC-Lis1, or control GFP at 3 DIV.were not only required for the asymmetric proteasome distribu-
tion, but also for axon growth and development. Pharmacologi-
cally, treating 2 DIV hippocampal neurons with dynein ATPase
inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA, 0.5 mM)Developme(Gibbons et al., 1978) or ciliobrevin D (Cilio D, 0.5 mM) for 2 hr
led to marked accumulation of endogenous proteasome sub-
units (e.g., Rpt1 and PA28) at all neurite tips (n = 20–25; Figures
2D, S2D, and S2E). In particular, the accumulation at axonal tipsntal Cell 35, 418–431, November 23, 2015 ª2015 Elsevier Inc. 421
reached1.7- to 3.0-fold of the average amount in the remaining
neurites (Figures 2D–2F and S2D). EHNA or Cilio D treatment
also led to short Tau-1-positive axon formation (Figure 2I).
Genetically, overexpressing p50/dynamitin or a C-terminal-trun-
cated lissencephaly protein (DC-Lis1, which lacks dynein-bind-
ing domain), which disrupts dynein-dynactin function in a domi-
nant-negative way (Sasaki et al., 2000; Tai et al., 2002; Tsai et al.,
2005), led to reduced retrograde proteasome transport and
enhanced proteasome accumulation at stage 2 nascent axon,
as well as defective neurite outgrowth and short axon phenotype
(Figures 2G–2I and S2F). Immunostaining the endogenous Par6
revealed that EHNA/Cilio D treatment abolished the accumula-
tion of Par6 at axon tips (Figures S2G and S2H), a physiological
abnormality in axon development. Thus, it appears that dynein-
dependent proteasome retrograde movements are required for
not only differential proteasome abundance, but also axon
growth and Par6 accumulation.
BDNF/cAMP Specifically Promotes Retrograde
Proteasome Transport in Axons
The enhanced retrograde transport of proteasomes observed
above emerged spontaneously in a homogeneous culturing
environment (Figures 2A–2C) and was found required for axon
growth and development (Figures 2D–2I and S2). In vivo, axon
development is often guided by environmental cues. To examine
whether enhanced retrograde transport can be regulated by
external stimuli, we first monitored the dynamics of MV151-
labled proteasomes in response to a bath application of axon-
promoting signals, e.g., autocrine factor BDNF or cAMP. Cells
were treated with BDNF (50 ng/ml) or the cAMP-elevating drug
forskolin (20 mM). In polarized cells, we found that BDNF or for-
skolin treatment increased the frequency of retrograde transport
in the longest process (the nascent axon), without significantly
affecting anterograde transport (Figures 3A, S3A, and S3E–
S3J). In unpolarized cells, forskolin indeed caused a reduction
of proteasome abundance at growing neurite tips, as indicated
by the changes of the fluorescence intensity of GFP-fused pro-
teasome subunit Rpt1 (see Figure S3B).
Next, we examined how protein degradation responds to gra-
dients of axon-promoting signals. We coated substrates with
stripes of BDNF or cAMP and monitored GFPu degradation in
hippocampal neurons cultured on these substrates. We found
that cells exhibited a higher rate of polarization (Figure S3C),
with both the GFPu intensity and neurite extension rate higher
at neurites grown on the stripes than those off the stripes (Fig-
ures S3C and S3D). A similar axon-promoting effect was also
observed in cells exposed to stripes of proteasome inhibitor
lacatacystin (Figure 3B). Thus, environmental cues can regulate
protein degradation or retrograde proteasome transport to
enhance neuron polarization and the growth of nascent axon.
The observed BDNF/cAMP-induced effects were specific to
BDNF/TrkB or cAMP/PKA signaling and depended on dynein
activity, as they were suppressed by tyrosine kinase inhibitor
K252a or specific PKA inhibitor KT5720 (200 nM) (Figure 3A),
as well as by a bath-application of 0.5 mM dynein motor in-
hibitor Ciliobrevin (Figure 3B). Furthermore, no significant
changes were observed in either frequency or directionality of
the anterograde KIF5B kinesin (tagged with luminol) that co-
transported with MV151-labeled proteasome puncta in axons422 Developmental Cell 35, 418–431, November 23, 2015 ª2015 Els(Figures S3H–S3J), suggesting that axon-promoting signals
selectively increase retrograde transport of proteasomes, pri-
marily at the expense of accumulated populations but not kine-
sin-mediated transport, to facilitate the proteasome removal
from axonal terminals.
BDNF/cAMP Reduces Protein Degradation in Axons
A consequence of the BDNF/cAMP-induced proteasome
removal from the axonal tip is a local increase in protein stability.
We applied a compartmented pulse-chase labeling technique to
determine the protein half-life (t1/2). Newly synthesized proteins
were labeled with L-azidohomoalaine (AHA) for 3 hr in both
axonal and somatodendritic compartments, followed by a
sequential chase at 12, 24, and 36 hr. Consistent with the differ-
ential proteasome abundance between axon and dendrites
(Figures 1D–1G), half-life of newly synthesized proteins in the so-
matodendritic region was significantly shorter than that at the
axonal tip (Figures S4A and S4B). Such differencewas enhanced
by axon-promoting signals, as shown in Figure S4Bwhere BDNF
treatment (50 ng/ml) prolonged the half-life in the axon tip from
12 to 22 hr, which was suppressed by pretreating cells with
TrkB inhibitor K252a, cAMP/PKA inhibitor KT5720, or dynein in-
hibitor EHNA, suggesting that the prolonged half-life was specif-
ically due to changes in transport.
Likewise, bath application of BDNF or cAMP to stage 3 neu-
rons induced an increase in GFPu intensity at the tip of axon
but not dendrites, and this effect did not depend on protein syn-
thesis since it was not suppressed by bath application of protein
synthesis inhibitor cycloheximide (Figures S4C and S4D).
Together, translation-independent effects of BDNF and cAMP
on the protein stability were concomitant with their promoting ef-
fects of axonal retrograde transport of proteasomes.
BDNF/cAMP Facilitates Proteasome Binding to
Retrograde Dynein Complexes
Without significant changes in kinesin-mediated transport, the
BDNF/cAMP-induced enhancement of retrograde proteasome
transport can occur in two ways: changes in microtubule polarity
or changes in dynein-proteasome association. To examine the
first possibility, we simultaneously analyzed microtubule polarity
and proteasome transport in 2 DIV hippocampal neurons. Cells
were infected to induce lentivirus-based expression of GFP
fused plus-end-binding protein 3 (EB3-GFP), followed by 1-hr
MV151 labeling. Kymographs of EB3-GFP comets in both unpo-
larized (stage 2) and polarized (stage 3) neurons showed a uni-
form microtubule polarity, with the majority (R90%) of plus
ends oriented distally (see Figures 3C and 3D). Thus, the prefer-
ential increase of retrograde proteasome transport was not due
to changes in microtubule polarity.
Next, we examined the possibility that dynein-proteasome as-
sociation was changed by BDNF/cAMP treatment. A potential
mechanism is activating adaptors that associate dynein with
proteasomes, such as the brain-enriched, proteasome-associ-
ated protein ‘‘extracellular mutant 29’’ (Ecm29). Ecm29 interacts
with microtubule-associated motor proteins, including Kinesin
light chain (KLC) and KIF1B (Gorbea et al., 2004, 2010). To ascer-
tain whether Ecm29 was involved in preferential retrograde pro-
teasome transport, we examined proteasome-dynein complex
formation in mouse brain lysates using MV151 labeling andevier Inc.
Figure 3. BDNF/cAMP Promotes Retrograde Proteasome Transport and Attenuates Protein Degradation in Axon
(A) Kymographs showing that bath application of BNDF led to an increase in the retrograde transport of proteasomes. Scale bar represents 30 s 3 50 mm.
Histograms depict changes in the percentage (±SEM, n = 10–30 cells for each group; *p < 0.01, t test) of stationary and mobile (retrograde and anterograde)
proteasomes before and after application of 50 ng/ml BDNF with or without pretreatment with tyrosine kinase inhibitor K252a or PKA inhibitor KT5720 (‘‘KT’’).
(B) Blockage of retrograde transport reduced BDNF-induced axon formation. Images of 3 DIV neurons grown on stripe coated with proteasome inhibitor lac-
tacystin, BDNF, or control fluorescently conjugated BSA with and without bath application of 0.5 mMCiliobrevin D (Cilio D; applied at 1DIV for 16 hr) as indicated.
Arrows represent the axon. Stripewidth represents 50 mm. Bar graphs showing the percentage of axon initiation on or off the stripes from all experiments similar to
that shown in the representative images. Only neurons with the soma located at the stripe boundary were counted. Data represent as mean ± SEM (>30 cells for
each group, n = 3; **p < 0.001, t test).
(C and D) No temporal correlation between the increased retrograde proteasome transport and changes in the pattern of microtubule orientation in developing
axons. (C) Hippocampal neurons transfected with GFP-EB3 were labeled with MV151 and analyzed with dual-color, time-lapse imaging (90 frames; 0.5 frames/s)
of EB-3 comets and proteasomes. (D) Changes in the microtubule orientation were not significant during stages 2 and 3 when a significant increase in retrograde
proteasome transport was observed. Data represent as mean ± SEM (>30 cells for each set of experiments, n = 3; **p < 0.001, n.s., no significant; compared with
stage 2 neurite, t test).sucrose-gradient sedimentation.We found that 19S proteasome
regulatory cap (Rpt1), dynactin subunit DCTN1, and Ecm29were
co-fractionated in heavier fractions (>19S), while anterograde
protein KLC and endosomal protein Rab5 were co-fractionated
with a subset of 20S proteasome a and b subunits in lighter
fractions (<5S). These data suggest that 26S proteasome and
adaptor Ecm29 were associated with retrograde dynein com-
plexes (Figure S5), while the anterograde kinesins primarily inter-
acted with individual proteasome subunits or vesicle-associated
subcomplexes (see Figure S5A, as in previous report; Otero
et al., 2014). In 3-DIV stage 3 neurons, confocal fluorescence mi-
croscopy further revealed that DCTN1 exhibited a higher co-
localization with endogenous proteasome subunit Rpt5 in the
growing axon than other neurites (Figure S5B), and its physical
association with MV151 labeled proteasomes was confirmed
by co-immunoprecipitation (Figure S5C).DevelopmeWestern blot also revealed a BDNF-enhanced Ecm29 binding
to proteasomes and/or dynein complexes in HEK293 cells co-
expressing flag-tag Ecm29 and BDNF receptor TrkB (HEK293
cells cannot respond to BDNF unless co-transfected with the re-
ceptor TrkB; Figures 4A and 4B); such enhancement was abol-
ished in cells pretreated with the TrkB or PKA inhibitor, K252a,
or KT5720 (Figures 4A and 4B). In vivo, dynein often forms com-
plexes with dynactin to associate with other molecules. We thus
assessedwhether forskolin treatment modulates the association
of Ecm29 with the p50/dynamitin subunit of the dynactin com-
plex. Although the binding maybe indirect, immunoprecipitated
endogenous Ecm29 exhibited detectable p50/dynamitin bind-
ing, while Ecm29-kinesin association was primarily mediated
by the tail cargo-binding domains of KIF5B (KIF5BDN331; Fig-
ure 4C). Furthermore, the BDNF/forskolin-enhanced Ecm29
binding was found specific to dynein complexes, as BDNF orntal Cell 35, 418–431, November 23, 2015 ª2015 Elsevier Inc. 423
Figure 4. BDNF/cAMP Facilitates Ecm29 Association with Proteasomes and Dynein Complexes
(A) BDNF increased Ecm29 binding with endogenous proteasomes and dynein complexes. 293T cells were co-transfected with TrkB and FLAG-tagged Ecm29.
After 18-hr transfection, cells were bath applied with and without BDNF (50 ng/ml) for 1 hr (K252a or K252bwas applied 30min prior to BDNF), and cell lysate was
immunoprecipitated by FLAG M2 antibody and blotted with antibodies targeted to Ecm29 (‘‘FLAG-Ecm29’’), phospho-(Ser/Thr) PKA substrates (‘‘p-FLAG-
Ecm29’’), dynactin subunit 1 (‘‘DCTN1’’), dynein intermediate chain 1 (‘‘DIC1’’), and proteasome 19S Rpt1 subunit (‘‘Rpt1’’), together with MV151-labeled pro-
teasome subunits (‘‘b1, b2, and b5’’). (Histograms) Summary of quantitative measurements of BDNF-induced changes in the level of MV151 signals and DIC1,
normalized to the band intensity measured from the corresponding immunoprecipitated FLAG-Ecm29 (±SEM, n = 3; **p < 0.001, compared with control, t test).
(B) Similar to (A), except cell lysates were immunoprecipitated by antibodies against KLC1 or DCTN1. (Histograms) Summary of quantitative measurements of
BDNF-induced changes in the level of MV151 signals, normalized to the band intensity measured from the corresponding KLC1 or DCTN1 (±SEM, n = 3,
compared with untreated control; **p < 0.001, t test).
(C) Similar to (A), except cells were co-transfected with p50-GFP and HA-KIF5B-DN331. Cell lysates were immunoprecipitated by antibodies against Ecm29.
Summary histograms below show that bath application of 20 mM forskolin for 15min significantly increased the level (±SEM, n = 3, compared to untreated control;
***p < 0.0001, t test of Ecm29 binding with p50/dynamitin, but not that with headless KIF5B (HA-KIF5B-DN331).
(D–H) Enhanced interaction of proteasomes with dynein complexes in response to BDNF/TrkB and cAMP/PKA signaling in developing neurons. (D) Confocal
images of cultured hippocampal neurons co-immunostained on 3 DIV for DIC1 and proteasome subunit Rpt3, showing an increase in the co-localization (yellow,
arrows) of Rpt3 staining (green) and DIC1 staining (red) after 1 hr bath application of BDNF. (E) Similar co-immunostaining and treatments procedure as in (B),
except 3D SIM images were acquired and analyzed for 3 DIV neurons. This is a representative surface rendering 3D images sampled from the distal end (20 mm) of
axons showing motor protein-positive puncta (DIC1 or KIF5B, green) and the calculated motor-proteasome co-localized surfaces (yellow, indicated by arrow).
The volume thickness is 3 mm. (F) Average percentage volume (±SEM, n = 8–10 cells for each set of experiments; t test) of proteasome subunits co-localized with
motors in the first (‘‘proximal’’) or last (‘‘distal’’) 20 mm region of axons. (G and H) Summary graphs showing the percentage volume (±SEM, n = 5–10 cells for each
set of experiment; **p < 0.001, ***p < 0.0001; t test) of Rpt3/Rpt5 puncta co-localized with DIC1/KIF5B in 3 DIV cultures that were exposed to BNDF (50 ng/ml,
30 min) or cAMP-elevating agent forskolin (20 mM), with and without pretreatment with K252a (200 nM), K252b (200 nM), or KT5720 (200 nM).
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forskolin treatment did not significantly affect or compete the
formation of anterograde kinesin-proteasome-Ecm29 com-
plexes (Figures 4B and 4C), consistent with the observation
that axon-promoting effects of BDNF/cAMP signaling primarily
acted on retrograde proteasome transport (Figures 3A, 3B,
S3A, and S3H).
We used confocal imaging and super-resolution 3D structured
illumination microscopy (3D SIM) to confirm BDNF/cAMP-in-
duced enhancement of proteasome-dynein complex formation
on axon in 3-DIV stage 3 neurons. As shown in Figure 4D, co-im-
munostaining of endogenous proteasome subunit Rpt3 and
cytoplasmic dynein intermediate chain subunit (DIC1) in un-
treated control cells revealed a punctate pattern along the
neurite with 16% of Rpt3 co-localizing with DIC1, and this
Rpt3-DIC1 co-localization was increased to 30% after bath
application of BDNF or forskolin. The increased Rpt3-DIC1 com-
plexes in the presence of BDNF were validated by co-localiza-
tion analysis obtained from 3D SIM images. The number and
the volume of Rpt3 co-distributed with DIC1 were significantly
increased in the presence of BDNF or forskolin (Figure 4D).
Such promoting effects were completely abolished by pretreat-
ing cells with TrKB or PKA inhibitor, K252a or KT5720. In con-
trast, the level of KIF5B kinesin co-distributed with proteasome
subunit Rpt5 was unaffected by BDNF treatment (Figures 4E
and 4H), confirming that BDNF signaling selectively enhances
recruitment of proteasome to retrogrademotor, without affecting
the anterograde complexes (Figures 3A, 3B, S3A, and S3H).
Adaptor Protein Ecm29 Is Required for Proteasome
Transport and Axon Growth
The BDNF/cAMP-enhanced retrograde proteasome transport
can be mediated by multiple pathways. To ascertain whether
dynein-Ecm29-proteasome interaction is solely responsible for
such an enhancement, we expressed ectopically N- and C-ter-
minal truncated forms of Ecm29 (denoted as Ecm291320–1840,
Ecm291032–1840, and Ecm291–1039, which are defective in protea-
some and dynein association, respectively (see Figure S6D)
(Gorbea et al., 2010). We found that ectopic expression of either
N- or C-terminal-truncated Ecm29 significantly reduced the level
of mobile MV151-labled proteasomes, as compared with cells
expressing WT Ecm29 (Figure 5A), indicating that both protea-
some and motor interaction domains of Ecm29 are required for
proteasome transport.
Downregulation of Ecm29 by specific shRNA (Figure S6) for
3 days yielded similar effects in reducing proteasome transport
(Figure 5A). Moreover, neurons expressing truncated Ecm29 or
Ecm29 shRNA displayed short axons and polarization defects,
while Ecm291320–1840 and Ecm291–1039 expressing neurons ex-
hibited a significant increase of no-axon (NA) cells, similar to neu-
rons expressing dynein-disrupting p50/dynamitin or treated with
dynein inhibitor (Figures 2I, 5B, and S2F). Thus, both proteasome
transport and proper axon development depend on intact
Ecm29 in vitro and in vivo.
BDNF/cAMP Promotes Retrograde Proteasome
Transport via Ecm29 Phosphorylation
If BDNF/cAMP-enhanced retrograde transport is due to activa-
tion of the adaptor Ecm29, one expects to see modification of
this protein in response to BDNF/cAMP treatment. In eukary-Developmeotes, most protein activations occur through phosphorylation.
To ascertain whether BDNF and cAMP signalings phosphorylate
Ecm29, we screened for potential phosphorylation sites of
Ecm29 by liquid chromatography-tandem mass spectrometry
and identified two BDNF/cAMP-responsive phosphorylation
sites, Ser1414 and Ser1661, at the C terminus of Ecm29 (Fig-
ure S7A). The specificity of BDNF/cAMP regulation of Ecm29
phosphorylation was confirmed by immunoprecipitation of
flag-tagged Ecm29 in cells treated with BDNF or forskolin;
such phosphorylation disappeared if cells were pretreated with
TrkB or PKA inhibitor (K252a or KT5720; Figure S7B). In addition,
immunofluorescence staining with specific antibodies against
Ecm29 or its phosphorylated form Ecm29S1414 or Ecm29S1661
showed that these proteins were primarily accumulated at axons
but not dendrites (Figures 6A, 6B, and S7C).
To ascertain whether Ecm29S1414/S1661 phosphorylation is
responsible for the enhanced proteasome-dynein association,
we assessed proteasome-Ecm29-motor association by western
blotting of immunoprecipitated FLAG-Ecm29 from HEK293 cells
co-expressing BDNF receptor TrkB with WT Ecm29 (Ecm29WT)
or Ecm29 phosphorylation variants, i.e., Ecm29S1414A/S1661A
and Ecm29S1414D/S1661D. As expected, cells expressing phos-
phorylation-mimicking Ecm29S1414D/S1661D exhibited a higher
binding affinity to both proteasome and dynein than Ecm29WT
(Figures 6C and 6D). In contrast, cells expressing phosphoryla-
tion-deficient Ecm29S1414A/S1661A were unresponsive to BDNF/
cAMP-enhanced interaction of either proteasome or dynein,
indicating that Ser1661 and Ser1414 phosphorylation is solely
responsible for promoting Ecm29-mediated proteasome-dynein
interaction (Figure 6C). Likewise, an ectopic expression of
Ecm29S1414A/S1661A reduced the percentage of retrograde
movements (Figures 6E and 6F). Thus, BDNF/cAMP signaling fa-
cilitates the formation of proteasome-dynein complexes through
Ecm29 phosphorylation, leading to increased retrograde trans-
port of proteasomes in growing axons.
Stage-Dependent Ecm29-Mediated Proteasome
Transport Can Be Explained by a Simple Model
The results above suggest that axon-promoting factors phos-
phorylate Ecm29 to enhance local protein stability (Figure S4),
as a local and global positive regulation manifested in the differ-
ential proteasome abundances between axon and dendrite tips.
Having sustainable axon growth requires cells to maintain such
asymmetry over long axons in a varying environment, which
has been a caveat in conventional Turing reaction-diffusive
scheme (Turing, 1952), as Turing model predicts cells to form
multiple positive regulation sites when cell size is beyond a
certain length scale. In this study, however, we observed that
the frequency of retrograde proteasome transport increased
with the axon lengths (Figures 2A and 2B). Theoretically, the
longer the axon, the more non-specific signals the cells could
experience from the environments. To gain a theoretical under-
standing on how the referential transport depends on axon
length and the strength of specific over nonspecific axon-pro-
moting signals, we developed a simple mathematical model. In
this model, we assumed that proteasomes are transported by
motor-associated Ecm29 and that Ecm29 switches the associ-
ated motor in a phosphorylation-dependent manner (see Sup-
plemental Information for details). While the specific signal wasntal Cell 35, 418–431, November 23, 2015 ª2015 Elsevier Inc. 425
Figure 5. Modulation of Proteasome Transport and Axon Growth by Ecm29
(A) Images of hippocampal neurons transfectedwith constructs expressing Ecm29 or shRNA against Ecm29 expression, stainedwithMV151 on 3DIV for 1 hr and
analyzed within kymographs as described in Figure 2A. Bar represents 25 mm. Summary histograms showing that either knocking down Ecm29 expression
(shRNA C+D) or disrupting Ecm29 binding to proteasome/motor reduced proteasomemobility. Data represent average number of events (±SEM, n = 20–35 cells
each; *p < 0.05; **p < 0.001, compared with controls, compared with Ecm29WT or SC-shRNA control, Dunnett’s test).
(B) Ectopic expression of N or C terminus truncated Ecm29 or knockdown Ecm29 expression by shRNA reduces axon growth. (Top) Images of cultured hip-
pocampal or cortical neurons expressing various forms of Ecm29. Bar represents 25 mm. (Bottom) summary of the average axon length (right) and percentage of
neurons (left) exhibiting different polarization phenotypes for the cultures described above. MA, multiple axons. Datasets (connected by dashed lines) showing
significant difference are marked (mean ± SEM, n = 90 cells; *p < 0.05, **p < 0.001, compared to corresponding sets in control, Dunnett’s test).created by Ecm29 phosphorylation at the axon tip, the non-
specific signals were implemented by allowing cells to express
non-convertible, constitutive active or defective Ecm29 (i.e.,
phosphorylation-mimicking or deficient), along with the WT. Us-
ing these simple assumptions, the model does produce the426 Developmental Cell 35, 418–431, November 23, 2015 ª2015 Elsspatial profiles of phosphorylated Ecm29, total Ecm29, and pro-
teasomes resembling those found in experiments (Figures 1D,
1E, 7A, and S7C).
Conversely, the model predicted that at the initial stage where
the nascent axon has a length similar to other neurites, theevier Inc.
Figure 6. PKA-Dependent Ecm29S1414/S1661 Phosphorylation Regulates Proteasome Transport
(A) Subcellular distribution of endogenous Ecm29 in newly polarized hippocampal neurons in DIV 1 cultures. Arrows, the axon.
(B) Average immunostaining intensity of Ecm29 and phosphorylated Ecm29 (p-Ecm29S1414 and p-Ecm29S1661) in the last 10 mm of the axon and dendrites. Error
bars are ± SEM (n = 3, 30 cell each; normalized to Tuj-1 intensity; **p < 0.001, t test).
(C) Western blots showing that Ecm29 phosphorylation at Ser1414 and Ser1661 increased Ecm29 binding to endogenous proteasome and dynein complexes.
(D) Quantitative measurements of average levels (±SEM, n = 4; **p < 0.001; ***p < 0.0001; compared with WT Ecm29 control, Dunnett’s test) of the FLAG-Ecm29
immunoprecipitated MV151 signals, DIC1, and KLC1 from experiments, as shown in (C), normalized to immunoprecipitated total Ecm29.
(E) Ecm29 phosphorylation facilitates retrograde proteasome transport. This is similar to that in Figure 5, except that the neuron was transfected with a phos-
phorylation mimicking (Ecm29S1414D, Ecm29S1661D, or Ecm29S1414D/S1661D) or defective construct (Ecm29S1414A, Ecm29S1661A, or Ecm29S1414A/S1661A).
(F) Frequencies of retrogradely versus anterogradely moving proteasomes, expressed as average counts (±SEM, n > 3, 10–15 neurons for each set of experi-
ments; *p < 0.05, **p < 0.001, t test) per 100 mm per min.enhanced retrograde proteasome transport created at the axon
tip is vulnerable to non-specific signals: overexpressing consti-
tutively active Ecm29 led to MA formation, while cells overex-
pressing defective Ecm29 failed to form axon (Figure 7B). To
test this prediction and to seewhether it is important for neuronal
development, we used cultures of rat embryonic cortical neu-
rons. Constructs encoding Ecm29WT or one of its mutated forms
were in utero electroporated (IUE; Saito and Nakatsuji, 2001) into
the developing brain of rat embryos on E17. Cultures were then
prepared right after electroporation. Such IUE method was used
for transfection of full-length Ecm29 constructs rather than lenti-
viral-based expression due to the constraint of construct size of
the lentivirion. At 3 DIV, the percentage of single axon (SA) cells
among Ecm29WT-expressing cortical neurons was comparableDevelopmeto that in non-transfected (control) neurons (Figures 7D). Consis-
tent with the model prediction, however, expressing either
Ecm29S1414A/S1661A or Ecm29S1414D/S1661D significantly reduced
the SA population. Notably, for the remaining populations,
Ecm29S1414A/S1661A expression greatly increased the NA popula-
tion and reduced neurite number and length, while the
Ecm29S1661D/S1414D expression increased the MA population
and neurite length, similar to those neurons treated with protea-
some inhibitors in previous studies (Cheng et al., 2011a; Yan
et al., 2006) (Figures 7D–7F and S1A). We also found polarization
defective phenotypes in neurons expressing Ecm29 phosphory-
lation variants at P3 rat cortices in vivo; such phenotypes can be
reduced by co-expressing WT Ecm29WT (Figures S6E–S6G).
These results are consistent with the model prediction andntal Cell 35, 418–431, November 23, 2015 ª2015 Elsevier Inc. 427
indicate that the initiation of axon strongly depends on specific
Ecm29 phosphorylation at Ser1414 and Ser1661.
To further investigate how neuron development depends on
specific over non-specific signals, we plated IUE neurons (trans-
fected with Ecm29WT or one of its mutated forms) on substrates
stripe coated with BDNF. For neurons with their somata located
at the stripe boundary on 3 DIV, we analyzed their distribution of
axon initiation site along their soma (Figure 7G). Similar to those
expressing Ecm29 mutants in regular cultures (Figure 7C), neu-
rons expressing Ecm29 mutants exhibited altered polarization
phenotypes on stripes (Figure 7G). Furthermore, both control
and Ecm29WT-expressing neurons showed higher probability
of axon differentiation for neurites initiated on the stripe than
off the stripe, whereas the axon-promoting effect of BDNF
stripes was diminished in neurons expressing Ecm29 mutants
(Figures 7G and 7H). Thus, Ecm29 phosphorylation is critical
for both spontaneous and BDNF-induced axon formation in
cortical neurons. Finally, the model predicts that the cellular
capability tomaintain the differential effect over non-specific sig-
nals increased with the axon length: once the cell passed the
initiation stage, its ability to maintain preferential transport
increased with the axon length (Figure 7I), which is consistent
with the experimental observation that 3-DIV neurons exhibited
a higher degree of preferential transport effects (Figure 2).
DISCUSSION
During neuronal maturation, redistribution of cytoplasmic con-
stituents and controlled protein turnover are essential for the
specification and development of axonal and dendritic compart-
ments. To achieve increasing demand of cytoplasmic constitu-
ents for the rapidly extending axon, previous studies have shown
that neurons may utilize several distinct mechanisms: (1) selec-
tive bulk flow of the cytoplasm into the growing axon (Bradke
and Dotti, 1997); (2) directional trafficking of proteins, mRNAs,
and organelles to the axon versus dendrites (Horton and Ehlers,
2003; Jung et al., 2014; Kapitein and Hoogenraad, 2011; Namba
et al., 2011; Rolls, 2011); (3) preferential stabilization or degrada-
tion of growth-associating proteins by selective regulating UPS
activity(Cheng et al., 2011a; Yan et al., 2006). In the present
study, we demonstrated that the abundance of multisubunit
mega-complex proteasomes may be spatially regulated in a
manner that contributes to the axon development during early
stages of neuronal differentiation. By direct observation of bidi-
rectional trafficking of proteasomes in developing neurons via
covalent labeling of active proteasomes with a specific reporter
MV151, we found a preferential increase of retrograde protea-
some transport that reduced proteasome abundance in the
distal end of growing axons, facilitating rapid axon extension.
Furthermore, we showed that the enhanced retrograde transport
was mediated by phosphorylation of adaptor protein Ecm29 that
promotes binding of proteasomes to the dynein motor. Such
global regulation of proteasome distribution may represent an
efficient mechanism of polarized distribution of proteins in the
cytoplasm (Figure 7I).
Proteasomes were previously thought to be diffusely distrib-
uted in nuclear and cytoplasmic compartments, and the distribu-
tion could be dynamically regulated by cytoskeleton-based
active transport or adaptor/scaffold protein interactions, during428 Developmental Cell 35, 418–431, November 23, 2015 ª2015 Elscell fate decision (Chang et al., 2011), growth cone steering,
and activity-induced synaptic modification (Bingol and Schu-
man, 2006; Bingol et al., 2010; Shen et al., 2007). For example,
unequal partitioning of proteasomes into two sibling cells of
proliferating T lymphocytes generates disparity in the abun-
dance of lineage-determining factors (Chang et al., 2011). We
found here that post-mitotic neurons generated patterns of pro-
teasome abundance by biasing retrograde versus anterograde
proteasome transport during the early period of active axon
growth. This preferential proteasome transport requiredmicrotu-
bule-associated dynein motors and could be upregulated by
stimulation with axon-promoting BDNF/cAMP/PKA signaling
pathway (Cheng et al., 2011b; Shelly et al., 2007), leading to dif-
ferential protein turnover between the axon and dendrites that
are required for local differentiation, metabolic demands, axon
pathfinding, and morphological changes of the growing axon.
For example, during the early phase of axon initiation, the
emerging asymmetry of proteasome transport could generate
an intracellular gradient of protein degradation along the nascent
axon that facilitates axon specification by accumulating axon
determinants at the distal end of the neurite. During axon path-
finding, bath application of proteasome inhibitor abolished
axon steering by extracellular guidance factors netrin and sem-
aphorin 3A (Campbell and Holt, 2001). Whether the asymmetry
of proteasome activity or distribution exists within the local re-
gion of the growth cone during axon steering remains to be
further investigated. Asymmetry of proteasome-dependent pro-
tein turnover must work in coordination with preferential mRNA
transport and local translation (Jung et al., 2014) in order to
achieve a myriad of structural and functional changes required
for neuronal development.
In addition to the induction of proteasome redistribution,
which alters regional capacity of protein turnover non-specif-
ically, BDNF/cAMP/PKA signaling also causes phosphorylation
of an E3 ligase Smurf1 that prevented and promoted the degra-
dation of Par6 and RhoA, two proteins having opposite functions
in regulating axon growth, respectively (Cheng et al., 2011a).
Thus, extracellular regulatory factors may exert both selective
and non-selective controls on local proteasome-dependent pro-
tein turnover, two complementary mechanisms for changes in
protein constituents in axonal versus somatodendritic compart-
ments of developing neurons. Alteration of the proteasome
substrate selectivity for positive and negative axon growth mod-
ulators could regulate the local levels of these modulators,
whereas the redistribution of proteasomes exerts a long-range
effect on the global capacity of protein turnover in different
neuronal compartments.
In this study, perhaps the most striking observation is that the
degree of the preferential transport effect increases with the
axon length, by which cell polarity can be sustainable over a
long distance in varying environments (Cheng et al., 2011a;
Namba et al., 2011). Both our experiments and modeling sug-
gest that this behavior results from transport-mediated removal:
the longer the axon, the less the proteasomes at axon tip. Conse-
quently, this phenomenon leads to global asymmetric protea-
some redistribution that may be of unique importance for neu-
rons because of the extensively compartmentalized neuronal
morphology. It is likely that regulation of proteasome activity
and transport plays a critical role in neuronal development asevier Inc.
Figure 7. Proper Axon Initiation Requires Specific Ecm29 Phosphorylation at Ser1414 and Ser1661
(A) Numerical results show the steady-state spatial profiles of phosphorylated Ecm29 (black), total Ecm29 (blue), and proteasomes (red) along the axon (solid line)
or dendrite (dashed line) measured from the soma (coordinate = 0) to the tip.
(B) At the axon initiation stage, numerical results show how the difference of proteasome concentrations at axon and dendrite tips (normalized by the soma
concentration) depends on the presence of phosphorylation-mimicking or deficient Ecm29 (normalized to the total amount of Ecm29). When phosphorylation-
mimicking (deficient) Ecm29 is overexpressed, cells were predicted to form multiple (no) axons.
See Supplemental Information for the details and the parameters.
(C–F) Ectopic expression of Ecm29S1414A/S1661A and Ecm29S1414D/S1661D altered axon formation. (C) Images of cultured cortical neurons expressing various forms
of Ecm29. Arrows show axons. Bar represents 25 mm. (D) Bar graphs showing the percentage of neurons (n = 3 cultures, 90 cells each) exhibiting three different
polarization phenotypes: SA, NA, or multiple axons (‘‘MA’’). Datasets (connected by dashed lines) showing significant difference aremarked (*p < 0.05, compared
with corresponding sets in WT Ecm29, Dunnett’s test). (E) Summary of the average axon length (±SEM) for the cultures described above in (B) (n = 51–90 cells;
*p < 0.05, **p < 0.001, compared with WT Ecm29, Dunnett’s test). (F) Composite tracing of axons from 25 randomly sampled 3 DIV neurons expressing various
forms of Ecm29.
(G and H) Ecm29 phosphorylation on Ser1414 and Ser1661 affected BDNF-induced axon initiation. (G) Images of cortical neurons expressing various forms of
Ecm29 with the axon initiated on or off the BDNF-coated stripes. Arrows show axons. Stripe width represents 50 mm. (H) Bar graphs of results from all ex-
periments, showing the percentage of axons that were initiated on or off the stripes coated with BDNF. Only neurons with the soma located at the stripe boundary
were counted. Data represent as mean ± SEM (n = 3, 30 cells each, **p < 0.001, t test).
(legend continued on next page)
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well as during regeneration and disease states, where there are
asymmetric demands for protein turnover at distant parts of the
neuron. The modulation of proteasome interaction with adaptor
proteins for transport motors shown here represents one of
many potential mechanisms for regulating proteasome redistri-
bution within the neuronal cytoplasm. For example, the develop-
ment of the cytoplasmic transport barrier at the axon initial
segment in mature neurons (Song et al., 2009) as well as
changes in the motor protein efficacy and microtubule-associ-
ated proteins could all play important roles in transport-depen-
dent regulation of local proteasome abundance in neurons.
EXPERIMENTAL PROCEDURES
Animal protocols were approved by the Academia Sinica Institutional Animal
Care and Utilization Committee.
Cell Culture Preparations and Immunostaining
Hippocampal neurons were prepared from rat embryos on E17 as previously
described (Dotti et al., 1988) and were cultured in neurobasal medium supple-
mented with Gem21 NeuroPlex (GEMINI bio-products). A similar procedure
was applied to the preparation for cortical neuronal cultures. Human Embry-
onic Kidney 293T cells used for biochemical assays were cultured in Dulbec-
co’s modification of Eagle’s medium supplemented with 5% fetal bovine
serum (BSA) (Sigma). Transfection of these cultures was performed using lenti-
virus-based expression system or Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s Instructions. Unless otherwise stated, hippocampal
neurons were used as a standard model for in vitro immunocytochemistry to
analyze axon/dendrite differentiation. Cortical neuronal cultures were used
for obtaining enough cells for biochemical assays that do not need transfection
of exogenous proteins.
For immunostaining, cultured hippocampal neurons were fixed with 4%
paraformaldehyde for 12 min and then permeabilized in 0.3% Triton X-100
for 20 min and blocked with 1% BSA for 1hr. The fixed cells were processed
further for immunostaining according to standard procedure and imaged with
a confocal microscope (Ziess LSM700) equipped with a 633 oil-immersion
objective (NA1.0). Images were analyzed and processed for presentation in
the figures, using brightness and contrast adjustments with NIH ImageJ soft-
ware and following the guideline of Rossner and Yamada (2004). Colocalization
ofRpt3-DIC1orRpt5-KIF3Bwasevaluatedusing structured illuminationmicro-
scopy (Ziess ELYRAPS1) equippedwith Plan Apo 633 oil-immersion objective
(NA1.4), and raw images were acquired with a total magnification of 79 nm per
cameral pixel with z spacing of 125 nm between planes. Imageswere analyzed
and processed using ZEN software (Zeiss) and Imaris software (Bitplane). Z
correction was applied to entire 3D image datasets.
Plasmids, Antibodies, and Materials
Detailed information is described in the Supplemental Experimental
Procedures.
Live-Cell Imaging and In-Gel Detection of Labeled Proteasome
Subunits
The fluorescent labeling of proteasomes were performed as described previ-
ously (Verdoes et al., 2006a). For live-cell imaging experiments, neurons were
bath incubated with 100 mMMV151/MV152 for 1 hr at 37C in culture medium
and visualized with a 63 oil-immersion objective (NA1.4; Zeiss) on a Zeiss Ob-
server.Z1 integrated with a camera AxioCam MRm and a temperature/CO2
modules. Zen blue (Zeiss) software was used for microscope control and
data acquisition. MV151 and MV152 were excited at lex = 543 nm and were
detected at 560–620 nm. For in-gel MV151-labeled proteasome detection,(I) Numerical simulations show how specific axon-promoting signals-mediated ax
once the cells break symmetry, the difference of proteasome concentrations (norm
the axon length (normalized by the dendrite length, with schematics shown on
Supplemental Information for the details and the parameters.
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MgCl2, 1 mM DTT, and 2 mM ATP) was incubated for 1 hr at 37
C with
MV151 (100 mM). Reaction mixtures were boiled with Laemmli’s buffer con-
taining b-mercapto-ethanol for 12 min and were resolved on 12% SDS-
PAGE. In-gel visualization was performed in the wet gel slabs directly on the
Typhoon FLA9000 laser scanner (lex = 532 nm, lem = 560; GE Healthcare
Life Sciences).
Statistics and Modeling
To decide the statistical test for the comparison between two datasets, we first
examined whether the data in each set are normally distributed, using Jarque-
Bera test. For datasets with normal distribution, t test was used. For compar-
ison involving multiple datasets, one-way ANOVA test was used followed by
post hoc Tukey test. Details for the numerical model and parameters for sim-
ulations can be found in Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.devcel.2015.10.018.
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